Chang, W.-T.; Chen, P.-W.; Lin, H.-W.; Kuo, Y.-H.; Lin, S.-H.; Li, Y.-H.
Risks of Aromatase Inhibitor-Related Cardiotoxicity in Patients with Breast Cancer in Asia. Cancers 2022, 14, 508.
https://doi.org/10.3390/cancers14030508
AMA Style
Chang W-T, Chen P-W, Lin H-W, Kuo Y-H, Lin S-H, Li Y-H.
Risks of Aromatase Inhibitor-Related Cardiotoxicity in Patients with Breast Cancer in Asia. Cancers. 2022; 14(3):508.
https://doi.org/10.3390/cancers14030508
Chicago/Turabian Style
Chang, Wei-Ting, Po-Wei Chen, Hui-Wen Lin, Yu-Hsuan Kuo, Sheng-Hsiang Lin, and Yi-Heng Li.
2022. "Risks of Aromatase Inhibitor-Related Cardiotoxicity in Patients with Breast Cancer in Asia" Cancers 14, no. 3: 508.
https://doi.org/10.3390/cancers14030508
APA Style
Chang, W. -T., Chen, P. -W., Lin, H. -W., Kuo, Y. -H., Lin, S. -H., & Li, Y. -H.
(2022). Risks of Aromatase Inhibitor-Related Cardiotoxicity in Patients with Breast Cancer in Asia. Cancers, 14(3), 508.
https://doi.org/10.3390/cancers14030508